Next step approval for emergency use authorization from the Food & Drug Administration. Today, Thursday, December 17, a FDA advisory committee voted 20 to 0, with one abstention, that the benefits of the Moderna (MRNA) coronavirus vaccine outweigh any risk.
Democratic and Republican attorney’s general from 38 states, led by Colorado and Nebraska, have filed an antitrust lawsuit against Google (GOOG). The suit alleges that Alphabet manipulates its search results to give its own products and services greater rankings over rivals—depriving web users from seeing the best options whenever they query the web for shopping, dining, and travel
Dividend Stock Portfolio member CVS Health (CVS) has set  December 21 for the start of its program to vaccinate residents of long-term care facilities with the Pfizer (PFE) vaccine expected to be approved today for emergency use.
Dow (DOW) certainly fits the dividend template that I’ve explained in my Special Report: “10 Dividend Stocks that are beating the risky rockets. The stock yields 5.26% after a 0.20% gain today December 9. That compares to a yield of just 2.8% in July 2017 and 3.1% in December 2016. The stock also shows a 1.06% price to sales ratio on today. I think we’re looking at a cheap stock. Tomorrow I’l be adding it to my Dividend Portfolio.
I’m adding Citigroup, the most recent pick in my Dividend Stocks Special Report, to my Dividend Portfolio tomorrow
As of Monday, December 7, I’m adding shares of Omnicom to my Jubak’s Picks Portfolio. The stock’s 4% yield indicates a company that is undervalued and ready to outperform during the post-vaccine rally.
Today, I made Eversource the fifth pick in my Special Report “Dividend Stocks that will beat the risky rockets.” On Monday, December 7, I will add the shares to my Jubak Picks portfolio. Eversource pays a 2.65% dividend.
Pfizer (PFE) stock tumbled Thursday after the company reportedly slashed its expectations for coronavirus vaccine deliveries in 2020 due to supply-chain issues. “Scaling up the raw material supply chain took longer than expected,” a company spokeswoman told the Wall Street Journal.Â
CNBC is reporting that a coalition of 40 U.S. states, led by New York, that have been investigating Facebook (FB)Â for potential antitrust violations plan to file a lawsuit against the company next week.
If you bought shares of Kensington Capital Acquisition (KCAC) along with me on October 13, you’re received a solicitation for a proxy vote to approve the reverse merger of Kensington with privately held QuantumScape, a startup solid state lithium battery company. The merger wis a way for Quantumscape to go public. (Kensington was the 14th and last pick in my Special Report: 10 Stocks for the Post-Coronavirus economy. Kensington has called a special meeting for shareholders for November 25 to approve the merger. You can vote online to 11:59 p.m. tonight. I plan to vote in favor of the merger, since that’s the whole reason for owning shares of Kensington.
Last night, I made Duke Energy (DUK) my second pick in my Special Report: “Dividend Stocks that are beating the Risky Rockets.” Today November 19, I’m adding these shares to my Dividend Portfolio.
I started off with utility stocks and I’ve now moved on to other dividend stocks within the general argument that dividend stocks–if you pick the right one–are perfect for the post-vaccine economy and stock market rally.
